Cognitive enhancers for the treatment of ADHD
- 1 August 2011
- journal article
- review article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 99 (2) , 262-274
Abstract
No abstract availableKeywords
This publication has 205 references indexed in Scilit:
- Alpha-2 Adrenergic Receptors and Attention-Deficit/Hyperactivity DisorderCurrent Psychiatry Reports, 2010
- Meta-analysis of the acute effects of nicotine and smoking on human performancePsychopharmacology, 2010
- Social cognition in attention-deficit hyperactivity disorder (ADHD)Neuroscience & Biobehavioral Reviews, 2010
- Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open‐label studyMovement Disorders, 2008
- In Vivo Activation of Midbrain Dopamine Neurons via Sensitized, High-Affinity α6∗ Nicotinic Acetylcholine ReceptorsNeuron, 2008
- Cingulate-Precuneus Interactions: A New Locus of Dysfunction in Adult Attention-Deficit/Hyperactivity DisorderBiological Psychiatry, 2008
- Testing for Neuropsychological Endophenotypes in Siblings Discordant for Attention-Deficit/Hyperactivity DisorderBiological Psychiatry, 2007
- Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: Focus on cognitionBiochemical Pharmacology, 2007
- Prevalence, Recognition, and Treatment of Attention-Deficit/Hyperactivity Disorder in a National Sample of US ChildrenArchives of Pediatrics & Adolescent Medicine, 2007
- Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2002